Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $2.18 and traded as low as $2.15. Organicell Regenerative Medicine shares last traded at $2.15, with a volume of 1,567 shares changing hands.
Organicell Regenerative Medicine Trading Down 2.3%
The firm has a fifty day simple moving average of $2.00 and a 200-day simple moving average of $2.18.
Organicell Regenerative Medicine Company Profile
Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Read More
- Five stocks we like better than Organicell Regenerative Medicine
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
